New innovations in Invitrogen EVOS M7000 microscope include high-end camera and more powerful computer CARLSBAD, Calif. — For biological researchers requiring high-quality images and data from their cells and samples without over-investing time and resources to get them, the fully automated Invitrogen EVOS M7000 microscope features a high-end camera and more powerful computer to deliver better […]

INTEGRA has responded to customers’ requests and developed two new 24-channel pipetting heads, extending the capabilities of its popular VIAFLO 96/384. Designed to make cell biology workflows more efficient and reliable, these handheld electronic pipettes allow plate filling, reagent addition or sample transfers to be performed in a single step, enabling quicker and more accurate […]

Biologic drugs are precision medicines which have revolutionised the treatment of chronic diseases such as cancer and inflammatory disorders. However, there are significant manufacturing challenges in translating these therapies to the market, due to a complex, time-consuming and labour-intensive manufacturing process. Andrew Alliance S.A., the robotics company that is improving laboratory workflow execution through the […]

In January 2019 Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, announced a technology partnering and collaboration agreement to enable rapid, high expression, stable cell line development. But what exactly are the tangible benefits gained from both parties and for customers, and why does this fusion of technology offer more […]

VICTORIA / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) has announced the purchase of its second state-of-the-art Intellicyt® iQue Screener PLUS for high-throughput cell-based screening. The demand for accelerated development of next-generation antibodies that recognize evermore challenging targets and have improved activities has prompted IPA to purchase further instrumentation […]

The REPROCELL group has signed a non-exclusive distributorship agreement with RUITAI Biotechnology (Shanghai) Ltd to distribute REPROCELL’s products in China. Through the RUITAI group’s offices in Shanghai, Hangzhou, and Shenyang, and combining with existing distributors in China, the agreement aims to broaden the reach of the products of the REPROCELL group to researchers and scientists […]

First commercially available, automated single-cell analysis application to enable co-detection of cellular protein and RNA expression using microfluidics technology SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, today announced the introduction of a REAP-seq (RNA expression and protein sequencing) protocol for use with the C1™ system. C1 REAP-seq is […]

Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has been granted de novo classification by the US Food and Drug Administration (FDA) for eight Cytocell Aquarius®Haematology fluorescence in situ hybridisation (FISH) probes for acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS). The probes form the largest FDA-cleared in vitro diagnostic (IVD)* FISH probe range for AML and MDS on the market […]

Investment received from Greenwood Way Capital, Oxford Technology and Innovations EIS Fund and 24Haymarket Funding will be used to accelerate growth in operations and sales across the UK and USA Cambridge, UK: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that is has closed a $2 million […]